tiprankstipranks
Trending News
More News >
Seres Therapeutics (MCRB)
NASDAQ:MCRB
US Market
Advertisement

Seres Therapeutics (MCRB) Technical Analysis

Compare
1,073 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Seres Therapeutics’s (MCRB) Moving Averages Convergence Divergence (MACD) indicator is 0.72, suggesting Seres Therapeutics is a Sell.
Seres Therapeutics’s (MCRB) 20-Day exponential moving average is 19.20, while Seres Therapeutics’s (MCRB) share price is $19.5, making it a Buy.
Seres Therapeutics’s (MCRB) 50-Day exponential moving average is 17.59, while Seres Therapeutics’s (MCRB) share price is $19.5, making it a Buy.

Seres Therapeutics (MCRB) Pivot Points

Oct 10, 2025, 06:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.26
18.78
19.21
19.73
20.16
20.68
21.10
Fibonacci
18.78
19.14
19.37
19.73
20.09
20.31
20.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Seres Therapeutics (MCRB) Moving Averages

Oct 10, 2025, 06:33 PM
Period
Simple
Exponential
MA5
20.16Sell
19.89Sell
MA10
19.92Sell
19.73Sell
MA20
18.68Buy
19.20Buy
MA50
17.83Buy
17.59Buy
MA100
13.93Buy
15.72Buy
MA200
13.87Buy
15.21Buy
Seres Therapeutics’s (MCRB) 10-Day exponential moving average is 19.73, while Seres Therapeutics’s (MCRB) share price is $19.5, making it a Sell.
Seres Therapeutics’s (MCRB) 100-Day exponential moving average is 15.72, while Seres Therapeutics’s (MCRB) share price is $19.5, making it a Buy.
Seres Therapeutics’s (MCRB) stock price is $19.5 and Seres Therapeutics’s (MCRB) 50-day simple moving average is 17.83, creating a Buy signal.
Seres Therapeutics’s (MCRB) stock price is $19.5 and Seres Therapeutics’s (MCRB) 100-day simple moving average is 13.93, creating a Buy signal.
Seres Therapeutics’s (MCRB) stock price is $19.5 and Seres Therapeutics’s (MCRB) 200-day simple moving average is 13.87, creating a Buy signal.

Seres Therapeutics (MCRB) Technical Indicators

Oct 10, 2025, 06:33 PM
Name
Value
Implied Action
RSI (14)
53.52
Neutral
STOCH (9,6)
40.96
Neutral
STOCHRSI (14)
63.54
Neutral
MACD (12,26)
0.72
Sell
ADX (14)
24.72
Neutral
Williams %R
-40.39
Buy
CCI (14)
49.12
Neutral
ATR (14)
1.59
-
Ultimate Oscillator
50.56
Neutral
ROC
11.75
Buy
Seres Therapeutics’s (MCRB) Relative Strength Index (RSI) is 53.52, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Trend Strength Indicator (ADX) is 24.72, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Commodity Channel Index (CCI) is 49.12, creating a Neutral signal.
Seres Therapeutics’s (MCRB) Price Rate of Change (ROC) is 11.75, creating a Buy signal.

FAQ

Is MCRB a Buy, Hold, or Sell?
Based on MCRB’s technical indicators, MCRB is a Buy.
    What is MCRB’s RSI (14)?
    MCRB’s RSI (14) is 53.52, which suggests MCRB is a Neutral.
      What is MCRB’s MACD?
      MCRB’s MACD is 0.72, which suggests MCRB is a Sell.
        What is MCRB’s 5-day moving average?
        MCRB’s 5-day moving average is 20.16, which suggests MCRB is a Sell.
          What is MCRB’s 20-day moving average?
          MCRB 20-day moving average is 18.68, which suggests MCRB is a Buy.
            What is MCRB’s 50-day moving average?
            MCRB’s 50-day moving average is 17.83, which suggests MCRB is a Buy.
              What is MCRB’s 200-day moving average?
              MCRB’s 200-day moving average is 13.87, which suggests MCRB is a Buy.
                What is MCRB’s Williams % R (14)?
                MCRB’s Williams % R (14) is -40.39, which suggests MCRB is a Buy.
                  What is MCRB’s CCI (14)?
                  MCRB’s CCI (14) is 49.12, which suggests MCRB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis